Literature DB >> 29373391

Integrated HIV-Care Into Primary Health Care Clinics and the Influence on Diabetes and Hypertension Care: An Interrupted Time Series Analysis in Free State, South Africa Over 4 Years.

Angeli Rawat1, Kerry Uebel2, David Moore3, Annalee Yassi1.   

Abstract

BACKGROUND: Noncommunicable diseases (NCDs), specifically diabetes and hypertension, are rising in high HIV-burdened countries such as South Africa. How integrated HIV care into primary health care (PHC) influences NCD care is unknown. We aimed to understand whether differences existed in NCD care (pre- versus post-integration) and how changes may relate to HIV patient numbers.
SETTING: Public sector PHC clinics in Free State, South Africa.
METHODS: Using a quasiexperimental design, we analyzed monthly administrative data on 4 indicators for diabetes and hypertension (clinic and population levels) during 4 years as HIV integration was implemented in PHC. Data represented 131 PHC clinics with a catchment population of 1.5 million. We used interrupted time series analysis at ±18 and ±30 months from HIV integration in each clinic to identify changes in trends postintegration compared with those in preintegration. We used linear mixed-effect models to study relationships between HIV and NCD indicators.
RESULTS: Patients receiving antiretroviral therapy in the 131 PHC clinics studied increased from 1614 (April 2009) to 57, 958 (April 2013). Trends in new diabetes patients on treatment remained unchanged. However, population-level new hypertensives on treatment decreased at ±30 months from integration by 6/100, 000 (SE = 3, P < 0.02) and was associated with the number of new patients with HIV on treatment at the clinics.
CONCLUSIONS: Our findings suggest that during the implementation of integrated HIV care into PHC clinics, care for hypertensive patients could be compromised. Further research is needed to understand determinants of NCD care in South Africa and other high HIV-burdened settings to ensure patient-centered PHC.

Entities:  

Mesh:

Year:  2018        PMID: 29373391     DOI: 10.1097/QAI.0000000000001633

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  11 in total

Review 1.  Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa.

Authors:  Samson Okello; Abdallah Amir; Gerald S Bloomfield; Katie Kentoffio; Henry M Lugobe; Zahra Reynolds; Itai M Magodoro; Crystal M North; Emmy Okello; Robert Peck; Mark J Siedner
Journal:  Prog Cardiovasc Dis       Date:  2020-02-05       Impact factor: 8.194

2.  Hypertension Control and Retention in Care Among HIV-Infected Patients: The Effects of Co-located HIV and Chronic Noncommunicable Disease Care.

Authors:  Brianna Osetinsky; Becky L Genberg; Gerald S Bloomfield; Joseph Hogan; Sonak Pastakia; Edwin Sang; Anthony Ngressa; Ann Mwangi; Mark N Lurie; Stephen T McGarvey; Omar Galárraga
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-01       Impact factor: 3.731

3.  Cardiovascular risk factors among ART-experienced people with HIV in South Africa.

Authors:  Emily P Hyle; Linda-Gail Bekker; Emily B Martey; Mingshu Huang; Ai Xu; Robert A Parker; Rochelle P Walensky; Keren Middelkoop
Journal:  J Int AIDS Soc       Date:  2019-04       Impact factor: 5.396

4.  Strengthening integration of chronic care in Africa: protocol for the qualitative process evaluation of integrated HIV, diabetes and hypertension care in a cluster randomised controlled trial in Tanzania and Uganda.

Authors:  Marie-Claire Van Hout; Max Bachmann; Jeffrey V Lazarus; Elizabeth Henry Shayo; Dominic Bukenya; Camila A Picchio; Moffat Nyirenda; Sayoki Godfrey Mfinanga; Josephine Birungi; Joseph Okebe; Shabbar Jaffar
Journal:  BMJ Open       Date:  2020-10-07       Impact factor: 2.692

5.  Integrating Care for Diabetes and Hypertension with HIV Care in Sub-Saharan Africa: A Scoping Review.

Authors:  Geoff McCombe; Jayleigh Lim; Marie Claire Van Hout; Jeffrey V Lazarus; Max Bachmann; Shabbar Jaffar; Anupam Garrib; Kaushik Ramaiya; Nelson K Sewankambo; Sayoki Mfinanga; Walter Cullen
Journal:  Int J Integr Care       Date:  2022-01-31       Impact factor: 5.120

6.  Future directions for HIV service delivery research: Research gaps identified through WHO guideline development.

Authors:  Nathan Ford; Ingrid Eshun-Wilson; Wole Ameyan; Morkor Newman; Lara Vojnov; Meg Doherty; Elvin Geng
Journal:  PLoS Med       Date:  2021-09-23       Impact factor: 11.069

7.  Leveraging HIV Care Infrastructures for Integrated Chronic Disease and Pandemic Management in Sub-Saharan Africa.

Authors:  Marie A Brault; Sten H Vermund; Muktar H Aliyu; Saad B Omer; Dave Clark; Donna Spiegelman
Journal:  Int J Environ Res Public Health       Date:  2021-10-13       Impact factor: 3.390

8.  Integrating HIV services and other health services: A systematic review and meta-analysis.

Authors:  Caroline A Bulstra; Jan A C Hontelez; Moritz Otto; Anna Stepanova; Erik Lamontagne; Anna Yakusik; Wafaa M El-Sadr; Tsitsi Apollo; Miriam Rabkin; Rifat Atun; Till Bärnighausen
Journal:  PLoS Med       Date:  2021-11-09       Impact factor: 11.069

9.  Effects of integrated models of care for diabetes and hypertension in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Anke Rohwer; Jeannine Uwimana Nicol; Ingrid Toews; Taryn Young; Charlotte M Bavuma; Joerg Meerpohl
Journal:  BMJ Open       Date:  2021-07-12       Impact factor: 2.692

10.  Integrating health services for HIV infection, diabetes and hypertension in sub-Saharan Africa: a cohort study.

Authors:  Josephine Birungi; Sokoine Kivuyo; Anupam Garrib; Sayoki Godfrey Mfinanga; Shabbar Jaffar; Levicatus Mugenyi; Gerald Mutungi; Ivan Namakoola; Janneth Mghamba; Kaushik Ramaiya; Duolao Wang; Sarah Maongezi; Joshua Musinguzi; Kenneth Mugisha; Bernard M Etukoit; Ayoub Kakande; Louis Wihelmus Niessen; Joseph Okebe; Tinevimbo Shiri; Shimwela Meshack; Janet Lutale; Geoff Gill; Nelson Sewankambo; Peter G Smith; Moffat J Nyirenda
Journal:  BMJ Open       Date:  2021-11-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.